235 related articles for article (PubMed ID: 17062763)
1. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome.
Cortón M; Botella-Carretero JI; Benguría A; Villuendas G; Zaballos A; San Millán JL; Escobar-Morreale HF; Peral B
J Clin Endocrinol Metab; 2007 Jan; 92(1):328-37. PubMed ID: 17062763
[TBL] [Abstract][Full Text] [Related]
2. Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome.
Chen L; Xu WM; Zhang D
Fertil Steril; 2014 Oct; 102(4):1167-1174.e4. PubMed ID: 25064406
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry.
Cortón M; Botella-Carretero JI; López JA; Camafeita E; San Millán JL; Escobar-Morreale HF; Peral B
Hum Reprod; 2008 Mar; 23(3):651-61. PubMed ID: 18156650
[TBL] [Abstract][Full Text] [Related]
4. Expression of visfatin mRNA in peripheral blood mononuclear cells is not correlated with visfatin mRNA in omental adipose tissue in women with polycystic ovary syndrome.
Seow KM; Hwang JL; Wang PH; Ho LT; Juan CC
Hum Reprod; 2011 Oct; 26(10):2869-73. PubMed ID: 21840905
[TBL] [Abstract][Full Text] [Related]
5. Increased regulated on activation, normal T-cell expressed and secreted levels and cysteine-cysteine chemokine receptor 5 upregulation in omental adipose tissue and peripheral blood mononuclear cells are associated with testosterone level and insulin resistance in polycystic ovary syndrome.
Juan CC; Chen KH; Chen CW; Ho CH; Wang PH; Chen HS; Hwang JL; Lin YH; Seow KM
Fertil Steril; 2021 Oct; 116(4):1139-1146. PubMed ID: 34119324
[TBL] [Abstract][Full Text] [Related]
6. Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with polycystic ovary syndrome.
Seow KM; Tsai YL; Hwang JL; Hsu WY; Ho LT; Juan CC
Hum Reprod; 2009 Aug; 24(8):1982-8. PubMed ID: 19423542
[TBL] [Abstract][Full Text] [Related]
7. Aquaglyceroporin-7 overexpression in women with the polycystic ovary syndrome.
Seow KM; Lin YH; Wang PH; Hwang JL; Ho LT; Juan CC
Gynecol Obstet Invest; 2013; 75(2):126-31. PubMed ID: 23235401
[TBL] [Abstract][Full Text] [Related]
8. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.
González F; Rote NS; Minium J; Kirwan JP
J Clin Endocrinol Metab; 2006 Jan; 91(1):336-40. PubMed ID: 16249279
[TBL] [Abstract][Full Text] [Related]
10. Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin.
Tan BK; Chen J; Digby JE; Keay SD; Kennedy CR; Randeva HS
J Clin Endocrinol Metab; 2006 Dec; 91(12):5022-8. PubMed ID: 17003086
[TBL] [Abstract][Full Text] [Related]
11. [Expression of insulin receptor substrate 1 and phosphorylation of tyrosine in adipose tissue of polycystic ovary syndrome].
Wang ZC; Gu XF; Yang DZ; Kuang JQ
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):120-3. PubMed ID: 15840294
[TBL] [Abstract][Full Text] [Related]
12. Adrenal androgen excess and body mass index in polycystic ovary syndrome.
Moran C; Arriaga M; Arechavaleta-Velasco F; Moran S
J Clin Endocrinol Metab; 2015 Mar; 100(3):942-50. PubMed ID: 25514100
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance.
Jones H; Sprung VS; Pugh CJ; Daousi C; Irwin A; Aziz N; Adams VL; Thomas EL; Bell JD; Kemp GJ; Cuthbertson DJ
J Clin Endocrinol Metab; 2012 Oct; 97(10):3709-16. PubMed ID: 22837189
[TBL] [Abstract][Full Text] [Related]
14. Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome.
Barber TM; Golding SJ; Alvey C; Wass JA; Karpe F; Franks S; McCarthy MI
J Clin Endocrinol Metab; 2008 Mar; 93(3):999-1004. PubMed ID: 18089693
[TBL] [Abstract][Full Text] [Related]
15. Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity.
Mlinar B; Marc J; Jensterle M; Bokal EV; Jerin A; Pfeifer M
J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):127-32. PubMed ID: 21147223
[TBL] [Abstract][Full Text] [Related]
16. A nontargeted proteomic study of the influence of androgen excess on human visceral and subcutaneous adipose tissue proteomes.
Montes-Nieto R; Insenser M; Martínez-García MÁ; Escobar-Morreale HF
J Clin Endocrinol Metab; 2013 Mar; 98(3):E576-85. PubMed ID: 23348399
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
Corbould A
Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
19. Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome.
Dumesic DA; Tulberg A; Leung KL; Fisch SC; Grogan TR; Abbott DH; Naik R; Chazenbalk GD
Fertil Steril; 2021 Jul; 116(1):232-242. PubMed ID: 33341231
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome.
González F; Minium J; Rote NS; Kirwan JP
J Clin Endocrinol Metab; 2005 Sep; 90(9):5336-42. PubMed ID: 15985479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
